Selected research
Industry Growth & Trends
Global NK Cell Cytotoxicity Assay Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global NK Cell Cytotoxicity Assay Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for NK Cell Cytotoxicity Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for NK Cell Cytotoxicity Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for NK Cell Cytotoxicity Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the NK Cell Cytotoxicity Assay Service market include Reaction Biology, Axion BioSystems, Sartorius, ICE Bioscience, Shanghai Saily Biotechnology, ProBio, Charles River, Imodels and Xeno Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global NK Cell Cytotoxicity Assay Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The NK Cell Cytotoxicity Assay Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global NK Cell Cytotoxicity Assay Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to NK Cell Cytotoxicity Assay Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global NK Cell Cytotoxicity Assay Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
NK Cell Cytotoxicity Assay Service Market by Company
Reaction Biology
Axion BioSystems
Sartorius
ICE Bioscience
Shanghai Saily Biotechnology
ProBio
Charles River
Imodels
Xeno Diagnostics
Cyagen
MarinBio
Pharmalegacy
Celentyx
Crown Bioscience
Cellomatics Biosciences
Agilent
Laboratories
Explicyte
NK Cell Cytotoxicity Assay Service Segment by Type
LDH (Lactate Dehydrogenase) Release Method
51Cr Release Method
Flow Cytometry Detection
Other
NK Cell Cytotoxicity Assay Service Segment by Application
Cancer Research
Infectious Disease Research
Immunotherapy Development
NK Cell Cytotoxicity Assay Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cell Cytotoxicity Assay Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NK Cell Cytotoxicity Assay Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cell Cytotoxicity Assay Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of NK Cell Cytotoxicity Assay Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- LDH (Lactate Dehydrogenase) Release Method
- 51Cr Release Method
- Flow Cytometry Detection
- Other
Applications
- Cancer Research
- Infectious Disease Research
- Immunotherapy Development
Companies covered
- Reaction Biology
- Axion BioSystems
- Sartorius
- ICE Bioscience
- Shanghai Saily Biotechnology
- ProBio
- Charles River
- Imodels
- Xeno Diagnostics
- Cyagen
- MarinBio
- Pharmalegacy
- Celentyx
- Crown Bioscience
- Cellomatics Biosciences
- Agilent
- Laboratories
- Explicyte
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global NK Cell Cytotoxicity Assay Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global NK Cell Cytotoxicity Assay Service Market Size by Region (2021-2032)
- 1.4.1 Global NK Cell Cytotoxicity Assay Service Market Size by Region (2021-2026)
- 1.4.2 Global NK Cell Cytotoxicity Assay Service Market Size by Region (2027-2032)
- 1.5 Key Regions NK Cell Cytotoxicity Assay Service Market Size (2021-2032)
- 1.5.1 North America NK Cell Cytotoxicity Assay Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe NK Cell Cytotoxicity Assay Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America NK Cell Cytotoxicity Assay Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size Growth Rate (2021-2032)
2 NK Cell Cytotoxicity Assay Service Market by Type
- 2.1 Type Introduction
- 2.1.1 LDH (Lactate Dehydrogenase) Release Method
- 2.1.2 51Cr Release Method
- 2.1.3 Flow Cytometry Detection
- 2.1.4 Other
- 2.2 Global NK Cell Cytotoxicity Assay Service Market Size by Type
- 2.2.1 Global NK Cell Cytotoxicity Assay Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global NK Cell Cytotoxicity Assay Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global NK Cell Cytotoxicity Assay Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global NK Cell Cytotoxicity Assay Service Market Size by Regions
- 2.3.1 North America NK Cell Cytotoxicity Assay Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe NK Cell Cytotoxicity Assay Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America NK Cell Cytotoxicity Assay Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa NK Cell Cytotoxicity Assay Service Market Size Breakdown by Type (2021-2026)
3 NK Cell Cytotoxicity Assay Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Cancer Research
- 3.1.2 Infectious Disease Research
- 3.1.3 Immunotherapy Development
- 3.2 Global NK Cell Cytotoxicity Assay Service Market Size by Application
- 3.2.1 Global NK Cell Cytotoxicity Assay Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global NK Cell Cytotoxicity Assay Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global NK Cell Cytotoxicity Assay Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global NK Cell Cytotoxicity Assay Service Market Size by Regions
- 3.3.1 North America NK Cell Cytotoxicity Assay Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe NK Cell Cytotoxicity Assay Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America NK Cell Cytotoxicity Assay Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa NK Cell Cytotoxicity Assay Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 NK Cell Cytotoxicity Assay Service Industry Trends
- 4.2 NK Cell Cytotoxicity Assay Service Industry Drivers
- 4.3 NK Cell Cytotoxicity Assay Service Industry Opportunities and Challenges
- 4.4 NK Cell Cytotoxicity Assay Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by NK Cell Cytotoxicity Assay Service Revenue (2021-2026)
- 5.2 Global NK Cell Cytotoxicity Assay Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global NK Cell Cytotoxicity Assay Service Key Company Headquarters & Area Served
- 5.4 Global NK Cell Cytotoxicity Assay Service Company, Product Type & Application
- 5.5 Global NK Cell Cytotoxicity Assay Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global NK Cell Cytotoxicity Assay Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 NK Cell Cytotoxicity Assay Service Players Market Share by Revenue in 2025
- 5.6.3 2025 NK Cell Cytotoxicity Assay Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Reaction Biology
- 6.1.1 Reaction Biology Company Information
- 6.1.2 Reaction Biology Business Overview
- 6.1.3 Reaction Biology NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Reaction Biology NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.1.5 Reaction Biology Recent Developments
- 6.2 Axion BioSystems
- 6.2.1 Axion BioSystems Company Information
- 6.2.2 Axion BioSystems Business Overview
- 6.2.3 Axion BioSystems NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Axion BioSystems NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.2.5 Axion BioSystems Recent Developments
- 6.3 Sartorius
- 6.3.1 Sartorius Company Information
- 6.3.2 Sartorius Business Overview
- 6.3.3 Sartorius NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sartorius NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.3.5 Sartorius Recent Developments
- 6.4 ICE Bioscience
- 6.4.1 ICE Bioscience Company Information
- 6.4.2 ICE Bioscience Business Overview
- 6.4.3 ICE Bioscience NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 ICE Bioscience NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.4.5 ICE Bioscience Recent Developments
- 6.5 Shanghai Saily Biotechnology
- 6.5.1 Shanghai Saily Biotechnology Company Information
- 6.5.2 Shanghai Saily Biotechnology Business Overview
- 6.5.3 Shanghai Saily Biotechnology NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Shanghai Saily Biotechnology NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.5.5 Shanghai Saily Biotechnology Recent Developments
- 6.6 ProBio
- 6.6.1 ProBio Company Information
- 6.6.2 ProBio Business Overview
- 6.6.3 ProBio NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 ProBio NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.6.5 ProBio Recent Developments
- 6.7 Charles River
- 6.7.1 Charles River Company Information
- 6.7.2 Charles River Business Overview
- 6.7.3 Charles River NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Charles River NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.7.5 Charles River Recent Developments
- 6.8 Imodels
- 6.8.1 Imodels Company Information
- 6.8.2 Imodels Business Overview
- 6.8.3 Imodels NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Imodels NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.8.5 Imodels Recent Developments
- 6.9 Xeno Diagnostics
- 6.9.1 Xeno Diagnostics Company Information
- 6.9.2 Xeno Diagnostics Business Overview
- 6.9.3 Xeno Diagnostics NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Xeno Diagnostics NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.9.5 Xeno Diagnostics Recent Developments
- 6.10 Cyagen
- 6.10.1 Cyagen Company Information
- 6.10.2 Cyagen Business Overview
- 6.10.3 Cyagen NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Cyagen NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.10.5 Cyagen Recent Developments
- 6.11 MarinBio
- 6.11.1 MarinBio Company Information
- 6.11.2 MarinBio Business Overview
- 6.11.3 MarinBio NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 MarinBio NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.11.5 MarinBio Recent Developments
- 6.12 Pharmalegacy
- 6.12.1 Pharmalegacy Company Information
- 6.12.2 Pharmalegacy Business Overview
- 6.12.3 Pharmalegacy NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Pharmalegacy NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.12.5 Pharmalegacy Recent Developments
- 6.13 Celentyx
- 6.13.1 Celentyx Company Information
- 6.13.2 Celentyx Business Overview
- 6.13.3 Celentyx NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Celentyx NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.13.5 Celentyx Recent Developments
- 6.14 Crown Bioscience
- 6.14.1 Crown Bioscience Company Information
- 6.14.2 Crown Bioscience Business Overview
- 6.14.3 Crown Bioscience NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Crown Bioscience NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.14.5 Crown Bioscience Recent Developments
- 6.15 Cellomatics Biosciences
- 6.15.1 Cellomatics Biosciences Company Information
- 6.15.2 Cellomatics Biosciences Business Overview
- 6.15.3 Cellomatics Biosciences NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Cellomatics Biosciences NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.15.5 Cellomatics Biosciences Recent Developments
- 6.16 Agilent
- 6.16.1 Agilent Company Information
- 6.16.2 Agilent Business Overview
- 6.16.3 Agilent NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Agilent NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.16.5 Agilent Recent Developments
- 6.17 Laboratories
- 6.17.1 Laboratories Company Information
- 6.17.2 Laboratories Business Overview
- 6.17.3 Laboratories NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Laboratories NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.17.5 Laboratories Recent Developments
- 6.18 Explicyte
- 6.18.1 Explicyte Company Information
- 6.18.2 Explicyte Business Overview
- 6.18.3 Explicyte NK Cell Cytotoxicity Assay Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Explicyte NK Cell Cytotoxicity Assay Service Product Portfolio
- 6.18.5 Explicyte Recent Developments
7 North America
- 7.1 North America NK Cell Cytotoxicity Assay Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026)
- 7.3 North America NK Cell Cytotoxicity Assay Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe NK Cell Cytotoxicity Assay Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026)
- 8.3 Europe NK Cell Cytotoxicity Assay Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America NK Cell Cytotoxicity Assay Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026)
- 10.3 South America NK Cell Cytotoxicity Assay Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst